Nuclear matrix targeting of the protein kinase CK2 signal as a common downstream response to androgen or growth factor stimulation of prostate cancer cells

Cancer Research

Volumn 59, Issue 5, 1999, Pages 1146-1151

  Guo, Chuanhai ^a   Yu, Shihui ^a   Davis, Alan T ^a   Ahmed, Khalil ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE;

ANTIBODY SPECIFICITY; ARTICLE; CARCINOMA CELL; CELL NUCLEUS MATRIX; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION; GENE TARGETING; GROWTH REGULATION; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STIMULUS RESPONSE; TUMOR GROWTH;

ADENOCARCINOMA; ANIMALS; CASEIN KINASE II; CELL DIVISION; CHROMATIN; CYTOSOL; DIHYDROTESTOSTERONE; DNA-BINDING PROTEINS; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 7; FIBROBLAST GROWTH FACTORS; GROWTH SUBSTANCES; HUMANS; KINETICS; MALE; NUCLEAR MATRIX; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RATS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR CELLS, CULTURED;

EID: 0033104342     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Williams-Ashman, H. G. Biochemical features of androgen physiology. In: L. J. DeGroot, G. F. Cahill, Jr., L. Martini, D. H. Nelson, W. D. Odell, J. T. Potts, Jr., E. Steinberger, and A. I. Winegard (eds.), Endocrinology, Vol. 3, pp. 1527-1533. New York: Grune and Stratton, 1979.
2. Coffey, D. S. Androgen action and the sex accessory tissues. In: E. Knobil and J. Neill (eds.), The Physiology of Reproduction, pp. 1081-1119. New York: Raven Press, 1988.
3. Liao, S., Kokontis, J., Sai, T., and Hiipakka, R. A. Androgen receptors: structures, mutations, antibodies and cellular dynamics. J. Steroid Biochem., 34: 41-51, 1989.
4. Schulze, H., and Isaacs, J. T. Biology and therapy of prostatic cancer. Cancer Surv., 5: 487-503, 1986.
5. McConnell, J. D. The pathophysiology of benign prostatic hyperplasia. J. Androl., 12: 356-363, 1991.
6. Stearns, M. E., and McGarvey, T. Prostate cancer: therapeutics, diagnostic, and basic studies. Lab. Investig., 67: 540-552, 1992.
7. Wilding, G. The importance of steroid hormones in prostate cancer. Cancer Surv., 14: 113-130, 1992.
8. Bruchovsky, N., Rennie, P. S., Coldman, A. J., Goldenberg, S. L., To, M., and Lawson, D. The effects of androgen withdrawal on the stem cell composition of Shionogi carcinoma. Cancer Res., 50: 2275-2282, 1990.
9. Kozlowski, J. M., Ellis, W. J., and Grayhack, J. M. Advanced prostatic carcinoma: early versus late endocrine therapy. Urol. Clin. N. Am., 18: 15-24, 1991.
10. Warner, J. A., and Heston, W. D. W. Future developments of nonhormonal systemic therapy for prostatic carcinoma. Urol. Clin. N. Am., 18: 25-33, 1991.
11. Steiner, M. S. Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy. J. Urol., 153: 1085-1096, 1995.
12. Ahmed, K. Significance of the casein kinase system in cell growth and proliferation with emphasis on studies of the androgenic regulation of the prostate. Cell. Mol. Biol. Res., 40: 1-11, 1994.
13. Ahmed, K., and Goueli, S. A. Androgenic regulation of prostatic protein phosphokinases and protein phosphorylation. In: G. Litwack (ed.), Biochem. Actions Horm., 14: 237-291. San Diego: Academic Press, 1987.
14. Liao, S., and Hiipakka, R. A. Mechanism of action of steroid hormones at the subcellular level. In: H. J. L. Makin (ed.), Biochemistry of Steroid Hormone Action, pp. 633-688. Oxford, United Kingdom: Blackwell Scientific Publishers, 1984.
15. Bruchovsky, N., Lesser, B., Van Doom, E., and Craven, S. Hormonal effects on cell proliferation in rat prostate. Vitam. Horm., 33: 61-102, 1975.
16. Pinna, L. A. Casein kinase 2: An "eminence grise" in cellular regulation? Biochim. Biophys. Acta, 1054: 267-284, 1990.
17. Tuazon, P. T., and Traugh, J. A. Casein kinase I and II multipotential serine protein kinases: structure, function, and regulation. Adv. Second Messenger Phosphoprotein Res., 23: 123-164, 1991.
18. Ahmed, K., Yenice, S., and Goueli, S. A. Casein kinases and prostatic cell growth. In: R. J. Wegmann and M. A. Wegmann (eds.), Recent Advances in Cellular and Molecular Biology, Vol. 4, pp. 7-15. Leuven, Belgium: Peeters Press, 1992.
19. Issinger, O-G. Casein kinases: pleiotropic mediators of cellular regulation. Pharmacol. Ther., 59: 1-30, 1993.
20. 2/M in Saccharomyces cerevisiae. J. Biol. Chem., 270: 25905-25914, 1995.
21. Tawfic, S., Faust, R. A., Gapany, M., and Ahmed, K. Nuclear matrix as an anchor for protein kinase CK2 nuclear signalling. J. Cell. Biochem., 61: 165-171, 1996.
22. Tawfic, S., and Ahmed, K. Association of casein kinase 2 (CK-2) with nuclear matrix: possible role in nuclear matrix protein phosphorylation. J. Biol. Chem., 269: 7489-7493, 1994.
23. Tawfic, S., and Ahmed, K. Growth stimulus-mediated differential translocation of casein kinase 2 to the nuclear matrix. J. Biol. Chem., 269: 24615-24620, 1994.
24. Tawfic, S., Davis, A. T., Faust, R. A., Gapany, M., and Ahmed, K. Association of protein kinase CK2 with nuclear matrix: influence of method of preparation of nuclear matrix. J. Cell. Biochem., 64: 499-504, 1997.
25. Guo, C., Davis, A. T., and Ahmed, K. Dynamics of protein kinase CK2 association with nucleosomes in relation to transcriptional activity. J. Biol. Chem., 273: 13675-13680, 1998.
26. Ahmed, K., Yenice, S., Davis, A., and Goueli, S. A. Association of casein kinase 2 (CK-2) with nuclear chromatin in relation to androgenic regulation of rat prostate Proc. Natl. Acad. Sci. USA, 90: 4426-4430, 1993.
27. Tawfic, S., Olson, M. O. J., and Ahmed, K. Role of protein phosphorylation in post-translational regulation of protein B23 during programmed cell death in the prostate gland. J. Biol. Chem., 270: 21009-21015, 1995.
28. Yenice, S., Davis, A. T., Goueli, S. A., Akdas, A., Limas, E., and Ahmed, K. Nuclear casein kinase 2 (CK2) activity in human normal, benign hyperplastic and cancerous prostate. Prostate, 24: 11-16, 1993.
29. Berezney, R. The nuclear matrix: a heuristic model for investigating genomic organization and function in the cell nucleus. J. Cell. Biochem., 47: 109-123, 1991.
30. Chen, N-Q., Davis, A. T., Canbulat, E. C., Liu, Y-X., Goueli, S., McKenzie, B. A., Eccleston, E. D., Jr., Ahmed, K., and Holtzman, J. L. Evidence that casein kinase 2 phosphorylates hepatic microsomal calcium-binding proteins 1 and 2 but not 3. Biochemistry, 35: 8299-8306, 1996.
31. Getzenberg, R. H., Pienta, K. J., Ward, W. S., and Coffey, D. S. Nuclear structure and the three-dimensional organization of DNA. J. Cell. Biochem., 47: 289-299, 1991.
32. Nickerson, J. A., He, D., Fey, E. G., and Penman, S. The nuclear matrix. In: P. R. Strauss and S. H. Wilson (eds.), The Eukaryotic Nucleus: Molecular Biochemistry and Macromolecular Assemblies, Vol. 2, pp. 763-782. Caldwell, NJ: Telford Press, 1990.
33. Stein, G. S., Stein, J. L., van Wijnen, A. J., and Lian, J. B. The maturation of a cell: three-dimensional structure of the nucleic acids in the timely expression of genes. Am. Sci., 84: 28-37, 1996.
34. Marshak, D. R., and Russo, G. L. Regulation of casein kinase CK2 during the cell cycle. Cell. Mol. Biol. Res., 40: 513-517, 1994.
35. Lorenz, P., Pepperkok, R., and Pyerin, W. Requirement of casein kinase 2 for entry into and progression through early phases of the cell cycle. Cell. Mol. Biol. Res., 40: 519-527, 1994.
36. Padmanabha, R., Chen-Wu, J. L. P., Hanna, D. E., and Glover, C. V. C. Isolation, sequencing, and disruption of the yeast CKA2 gene: casein kinase II is essential for viability in Saccharomyces cerevisiae. Mol. Cell. Biol., 10: 4089-4099, 1990.
37. TAK) and casein kinase 2 in human squamous cell carcinomas and adenocarcinomas of the lung. Cancer Res., 54: 2262-2268, 1994.
38. Gapany, M., Faust, R. A., Tawfic, S., Davis, A., and Ahmed, K. Association of elevated protein kinase CK2 activity with aggressive behavior of squamous cell carcinoma of the head and neck. Mol. Med., 1: 659-666, 1995.
39. Faust, R. A., Gapany, M., Tristani, P., Davis, A. T., Adams, G. L., and Ahmed, K. Elevated protein kinase CK2 in chromatin of head and neck tumors: association with malignant transformation. Cancer Lett., 101: 31-35, 1996.
40. Kelliher, M. A., Seldin, D. C., and Leder, P. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIα. EMBO J., 15: 5160-5166, 1996.
41. Seldin, D. C., and Leder, P. Casein kinase 2α-induced murine lymphoma: relation to theileriosis in cattle. Science (Washington DC), 267: 894-897, 1995.
42. Landesman-Bollag, E., Channavajhala, P. L., Cardiff, R. D., and Seldin, D. C. p53 deficiency and misexpression of protein kinase CK2α collaborate in the development of thymic lymphomas in mice. Oncogene, 16: 2965-2974, 1998.
43. Yu, S., Davis, A. T., Guo, C., Green, J. E., and Ahmed, K. Differential targeting of protein kinase CK2 to the nuclear matrix upon transient overexpression of its subunits. J. Cell. Biochem., in press, 1999.